WallStSmart
IDYA

Ideaya Biosciences Inc

NASDAQ: IDYA · HEALTHCARE · BIOTECHNOLOGY

$28.05
-3.41% today

Updated 2026-04-29

Market cap
$2.46B
P/E ratio
P/S ratio
11.26x
EPS (TTM)
$-1.28
Dividend yield
52W range
$17 – $39
Volume
1.3M

Ideaya Biosciences Inc (IDYA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
+42.4%
Last 4 quarters
Revenue YoY growth
+55.4%
Most recent quarter
EPS YoY growth
+36.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.5%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-5.5%
2025-08-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$-0.94-0.3%$31.45$32.48+3.3%
2025-11-04$1.33+341.8%$31.36$29.66-5.4%
2025-08-05$-0.88-11.4%$25.00$23.63-5.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.94$-0.94-0.3%$10.88M+55.4%
2025-09-30$-0.55$1.33+341.8%$207.83M
2025-06-30$-0.79$-0.88-11.4%
2025-03-31$-0.69$-0.82-18.8%
2024-12-31$-0.62$-1.49-139.4%$7.00M+78.4%
2024-09-30$-0.63$-0.60+4.8%
2024-06-30$-0.54$-0.68-25.9%
2024-03-31$-0.51$-0.53-3.9%
2023-12-31$-0.47$-0.52-10.6%$3.92M
2023-09-30$-0.49$-0.46+6.1%$8.04M
2023-06-30$-0.56$-0.50+10.7%$3.54M

Frequently asked questions

Has Ideaya Biosciences Inc beaten earnings estimates?
Ideaya Biosciences Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of +42.4% over the last 4 quarters.
How does IDYA stock react to earnings?
IDYA stock has moved an average of -2.5% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Ideaya Biosciences Inc's revenue growth rate?
Ideaya Biosciences Inc reported year-over-year revenue growth of +55.4% in its most recent quarter, with EPS growing +36.9% year-over-year.